AJR InPractice
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dulce, M. C.
Right arrow Articles by Higgins, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dulce, M. C.
Right arrow Articles by Higgins, C. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 160, 963-970, Copyright © 1993 by American Roentgen Ray Society


ARTICLES

MR imaging of the myocardium using nonionic contrast medium: signal- intensity changes in patients with subacute myocardial infarction

MC Dulce, AJ Duerinckx, J Hartiala, GR Caputo, M O'Sullivan, MD Cheitlin and CB Higgins
Department of Radiology, University of California, Medical School, San Francisco 94134.

OBJECTIVE. Gadodiamide injection (Omniscan, Sanofi Winthrop Pharmaceuticals, New York) is a new nonionic MR contrast medium that has been shown in animal studies to provide persistent differential enhancement of myocardial infarction. Because differential enhancement of normal and infarcted myocardium may be useful for the diagnosis and sizing of myocardial infarctions, we assessed the effectiveness of gadodiamide injection in enhancing signal-intensity differences between infarcted and normal myocardium on spin-echo T1-weighted images. SUBJECTS AND METHODS. Signal intensity of normal and infarcted myocardium, contrast ratio, contrast-to-noise ratio, and signal-to- noise ratio were measured in 12 patients with subacute myocardial infarction (mean, 16 days after diagnosis) before and after injection of contrast medium. Precontrast T1-weighted and T2-weighted images were obtained with a 1.5-T MR imager. T1-weighted images were acquired 5, 15, and 30 min after gadodiamide injection (0.2 mmol/kg) and T1- weighted images with fat saturation were acquired 10 min after gadodiamide injection. RESULTS. Gadodiamide injection significantly increased signal intensity of normal (34 +/- %) and infarcted (90 +/- %) myocardium compared with their signal intensities on precontrast T1- weighted images. The contrast ratio was significantly increased, and the augmented ratios persisted throughout the 45-min observation period. The contrast ratio on T2-weighted images was comparable to that on contrast-enhanced T1-weighted images (with or without the use of fat saturation). However, the signal-to-noise and contrast-to-noise ratios of T2-weighted images were significantly lower than those of contrast- enhanced T1-weighted images. The maximum contrast-to-noise ratio for visualizing myocardial infarction was achieved on contrast-enhanced T1- weighted images with fat saturation. CONCLUSION. Improved and persistent contrast between infarcted and normal myocardium can be produced on MR images by injecting gadodiamide at a dose of 0.2 mmol/kg, which provides prolonged delineation of myocardial infarctions. Maximum contrast-to-noise ratios for detecting myocardial infarction can be produced by using fat-saturated T1-weighted imaging after a high dose of this nonionic contrast medium has been administered.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadioGraphicsHome page
J. Vogel-Claussen, C. E. Rochitte, K. C. Wu, I. R. Kamel, T. K. Foo, J. A. C. Lima, and D. A. Bluemke
Delayed enhancement MR imaging: utility in myocardial assessment.
RadioGraphics, May 1, 2006; 26(3): 795 - 810.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. R. Edelman
Contrast-enhanced MR Imaging of the Heart: Overview of the Literature
Radiology, September 1, 2004; 232(3): 653 - 668.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
A. J. Duerinckx
Myocardial Viability Using MR Imaging: Is It Ready for Clinical Use?
Am. J. Roentgenol., June 1, 2000; 174(6): 1741 - 1743.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Roentgen Ray Society.